Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) Enterprise Value (2018 - 2026)

Neuronetics has reported Enterprise Value over the past 11 years, most recently at -$9.7 million for Q1 2026.

  • Quarterly Enterprise Value rose 43.56% to -$9.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$9.7 million through Mar 2026, up 43.56% year-over-year, with the annual reading at -$2.4 million for FY2025, 181.85% down from the prior year.
  • Enterprise Value was -$9.7 million for Q1 2026 at Neuronetics, down from -$2.4 million in the prior quarter.
  • Over five years, Enterprise Value peaked at $2.9 million in Q4 2024 and troughed at -$82.9 million in Q1 2022.
  • The 5-year median for Enterprise Value is -$43.3 million (2024), against an average of -$39.4 million.
  • Year-over-year, Enterprise Value soared 104.77% in 2024 and then tumbled 181.85% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$71.9 million in 2022, then grew by 15.72% to -$60.6 million in 2023, then surged by 104.77% to $2.9 million in 2024, then tumbled by 181.85% to -$2.4 million in 2025, then plummeted by 309.48% to -$9.7 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's Enterprise Value are -$9.7 million (Q1 2026), -$2.4 million (Q4 2025), and -$24.1 million (Q3 2025).